site background
Skip to content
Ivy Brain Tumor Center
Trial EligibilityDonate
Main Menu
  • Physicians
  • Industry
  • Ivy Blog
Talk to an Ivy Navigator
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Clinical Trials
    • Current Trials
      • SONODYNAMIC THERAPY IN RECURRENT GLIOBLASTOMA
      • AZD1390 For Recurrent Grade IV Glioma
      • Sonodynamic Therapy in Recurrent High-Grade Glioma
      • Niraparib for Newly Diagnosed Glioblastoma
      • Pamiparib for newly diagnosed or recurrent glioblastoma
      • Abemaciclib Plus LY3214996 For Recurrent Glioblastoma
      • Sonodynamic Therapy in DIPG
      • Infigratinib in Recurrent Glioblastoma Patients
      • RIBOCICLIB FOR RECURRENT GLIOBLASTOMA
      • RIBOCICLIB FOR RECURRENT MENINGIOMA
    • What is a Phase 0 Trial?
    • Why Ivy Clinical Trials?
    • What We Treat
      • Gliomas
      • Brain Metastases
      • Meningiomas
      • Ependymomas
      • Craniopharyngiomas
      • Pineal-Region Tumors
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
      • Lodging
      • Transportation
    • Patient Support
    • FAQs
    • Share Your Story
  • Research
    • Scientific Cores
    • Laboratories
      • Mehta Laboratory
      • Tovmasyan Laboratory
      • Tien Laboratory
      • Mirzadeh Laboratory
    • Certifications
    • Preclinical Work
    • Industry Collaboration
    • Published Research
    • Ivy Center Seminar Series
  • About
    • Team
      • Administration
      • Business Operations
      • Clinical Operations
      • Communications
      • Preclinical and Translational Science
      • Clinicians
    • New Ivy Headquarters
    • It’s personal
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Donate
    • Careers
    • Contact Us
  • ESPAÑOL

Talk to an Ivy Navigator

602-406-8605
Home » About » Team » Shwetal Mehta, PhD
Headshot of Shwetal Metah
  • phone:(602) 406-5210
  • Send Email

Shwetal Mehta, PhD

Chief Operating Officer, Deputy Director, Pre-Clinical Core Leader

Dr. Shwetal Mehta received her Master’s Degree from Tata Institute of Fundamental Research, India, in Molecular Biology. She then earned her PhD in Molecular Genetics and Microbiology from The University of Texas at Austin in 2003.  She completed her postdoctoral work in the Stiles Laboratory at the Dana-Farber Cancer Institute and Harvard Medical School. Her postdoctoral work was focused on the identification of a potential therapeutic target for high-grade gliomas.

As Deputy Director of the Ivy Brain Tumor Center, Dr. Mehta is a recognized leader in translational science for brain tumors and has helped develop an array of early-phase pharmacodynamic- and pharmacokinetic-driven studies for patients with malignant brain tumors.  As a Principal Investigator within the Ivy Center, her expertise in molecular biology and the signaling pathways driving glioma biology is essential to our Phase 0 clinical trials program.

Arial shot of the Ivy Brain Tumor Center
Ivy Brain Tumor Center
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Phase 0 Clinical Trials
    • Why Ivy Clinical Trials?
    • What We Treat
    • Brain Tumor Clinical Trials
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
    • Patient Support
    • FAQs
  • About
    • Team
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Donate
    • Careers
    • Contact Us

Stay Updated

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

2910 North Third Avenue
Phoenix, Arizona 85013
(602) 406-6489
[email protected]
Mailing Address for Donations »

© Ivy Brain Tumor Center, 2023. All Rights Reserved.
  • Privacy Policy
  • Site Map
Important Notice

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device.